RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13

Jul 12, 2025 - 22:00

0

RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13

Related Posts

Atea Pharmaceuticals Issues Statement Regarding Director Nominations

Atea Pharmaceuticals Issues Statement Regarding Directo...

Mar 21, 2025 3

Dream Finders Homes director Lovett sells $2.65 million in stock

Dream Finders Homes director Lovett sells $2.65 million...

Mar 21, 2025 0

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

Mar 21, 2025 0

Factbox-What fighter jet programs does the US Air Force have?

Factbox-What fighter jet programs does the US Air Force...

Mar 21, 2025 1

Airlines issue travel waivers due to London's Heathrow Airport shutdown

Airlines issue travel waivers due to London's Heathrow ...

Mar 21, 2025 0

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 4